Patents Assigned to Can-Fite Biopharma Ltd. Israel
  • A3AR agonists for the treatment of inflammatory arthritis
    Patent number: 7141553
    Abstract: The present invention concerns a method for the treatment of inflammatory arthritis, and in particular rheumatoid arthritis, by administering to the subject specific low dosages of N6-(3-iodobenzyl)-adenosine 5?-N-methyl-uronamide (IB-MECA) and 2-chloro-N6-(3-iodobenzyl)-adenosine-5?-N-methyl-uronamide (CL-IB-MECA).
    Type: Grant
    Filed: November 19, 2003
    Date of Patent: November 28, 2006
    Assignee: Can-Fite Biopharma Ltd. Israel
    Inventor: Pnina Fishman